2020 JITC Best Paper Award Recipients

The Journal for ImmunoTherapy of Cancer (JITC) Best Paper Awards celebrate excellence in scientific research and are awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts. Papers published in the last 12 months authored by Society for Immunotherapy of Cancer (SITC) members were eligible for nomination for this award.

JITC Best Basic Science Paper

Articles nominated in this category present innovative research in basic medical sciences that have a direct relevance to future research in clinical medicine.

Shuming Chen, PhD

John Hopkings University School of Medicine

"Mechanisms regulating PD-L1 expression on tumor and immune cells"
Shuming Chen, George A. Crabill, Theresa S. Pritchard, Tracee L. McMiller, Ping
Wei, Drew M. Pardoll, Fan Pan and Suzanne L. Topalian

Journal for ImmunoTherapy of Cancer 2019, 7:305 (15 November 2019)

JITC Best Clinical/Translational Paper

Papers in this category present clinical research that has a clear potential to optimize patient care, with particular emphasis on high quality randomized controlled trials, novel combination treatments, therapies, novel diagnostic or prognostic insights and new insights into mechanism of action.

Bryan D. Choi, md, phd

Massachusetts General Hospital

"CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma"
Bryan D. Choi, Xiaoling Yu, Ana P. Castano, Henia Darr, Daniel B. Henderson,
Amanda A. Bouffard, Rebecca C. Larson, Irene Scarfò, Stefanie R. Bailey,
Genevieve M. Gerhard, Matthew J. Frigault, Mark B. Leick, Andrea Schmidts,
Jason G. Sagert, William T. Curry, Bob S. Carter and Marcela V. Maus

Journal for ImmunoTherapy of Cancer 2019, 7:302 (14 November 2019)